NEW YORK (EGMN) – Findings in 10 key investigative areas, from platelet inhibition and left main coronary artery disease to the use of fractional flow reserves and the "kissing" stent could have a profound impact on interventional cardiology in the next year or so.
Dr. Samin K. Sharma, co-director of the Cardiovascular Institute at Mt. Sinai Medical Center in New York, provided his take on these findings at the Mt. Sinai Live Symposium of Complex Coronary and Vascular Cases.
They are as follows:
Clopidogrel resistance and proton pump inhibitor (PPI) interaction studies.
In March, the FDA issued a warning that clopidogrel, widely prescribed to patients who have had a heart attack or stroke, is not as effective in people who cannot metabolize the drug. Dr. Sharma cited numerous reports that have shown that PPI drugs inhibit the activity of clopidogrel. In the clinic, physicians can test patients for platelet inhibition and use that data accordingly to modify dosing of the PPI.
"Avoid routine use of PPI with clopidogrel," Dr. Sharma said. "If proton pump inhibition is needed, use H2 receptor blockers instead. If you need to use a PPI, many studies have shown it to be safer to use clopidogrel in the morning and the PPI in evening." In high-risk patients, he advised using a 600-mg loading dose of PPI, then 150 mg daily. While genetic testing may help identify vulnerable groups, he added, it's "a very complex issue cost wise."
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.